Cochrane Abstracts
Febuxostat for treating chronic gout
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Febuxostat for Treating Chronic Gout." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433467/all/Febuxostat_for_treating_chronic_gout.
Febuxostat for treating chronic gout. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433467/all/Febuxostat_for_treating_chronic_gout. Accessed January 30, 2025.
Febuxostat for treating chronic gout. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433467/all/Febuxostat_for_treating_chronic_gout
Febuxostat for Treating Chronic Gout [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433467/all/Febuxostat_for_treating_chronic_gout.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Febuxostat for treating chronic gout
ID - 433467
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433467/all/Febuxostat_for_treating_chronic_gout
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
